MARKET

CDNA

CDNA

CareDx
NASDAQ

Real-time Quotes | Nasdaq Last Sale

23.61
+0.10
+0.43%
After Hours: 23.61 0 0.00% 16:30 01/17 EST
OPEN
23.72
PREV CLOSE
23.51
HIGH
24.21
LOW
23.31
VOLUME
735.34K
TURNOVER
--
52 WEEK HIGH
41.27
52 WEEK LOW
18.75
MARKET CAP
1.00B
P/E (TTM)
-46.8918
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of CDNA and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

CDNA News

  • CareDx Sees Q4 Sales $35.7M-36M vs $34.15M Est
  • Benzinga.5d ago
  • CareDx Raises FY2019 Sales Guidance from $124M-125M to $127M-127.3M
  • Benzinga.5d ago
  • CareDx Reports Preliminary Fourth Quarter and Full Year 2019 Results
  • GlobeNewswire.5d ago
  • CareDx Reports AlloSeq cfDNA Wins CE Mark Approval
  • Benzinga.01/10 12:03

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About CDNA

CareDx, Inc. is a molecular diagnostics company. The Company is focused on the discovery, development and commercialization of clinically differentiated diagnostic surveillance solutions for transplant patients. The Company's commercialized testing solution, the AlloMap heart transplant molecular test (AlloMap), is a gene expression test that helps clinicians monitor and identify heart transplant recipients with stable graft function having a low probability of moderate/severe acute cellular rejection. Its products under development for transplant monitoring include AlloSure, a development-stage transplant surveillance solution, which applies next generation sequencing to detect and quantitate genetic differences between donor-derived cell-free deoxyribonucleic acid (dd-cfDNA) in the blood stream emanating from the donor heart. It offers the AlloMap Score Variability service, which provides complementary information to help personalize long-term care of heart transplant recipients.
More

Webull offers CareDx Inc (CDNA) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.